Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus

British Journal of Ophthalmology

Volumn 83, Issue 7, 1999, Pages 834-837

  Shinoda, Kei ^a   Ishida, Susumu ^a   Kawashima, Shinichi ^a   Wakabayashi, Toshiko ^a   Matsuzaki, Tadayuki ^a   Takayama, Michiyo ^a   Shinmura, Ken ^a   Yamada, Masakazu ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; VASCULOTROPIN;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE SURGERY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0032800916     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.7.834     Document Type: Article

References (38)

1. Prevent Blindness America. Vision problems in the US: a report on blindness and vision impairment in adults age 40 and older. Schaumburg, IL: Prevent Blindness America, 1994.
2. Kohner E, Henkind P Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 1970;69:403-14.
3. Bresnik GH, David MD, Myers FL, et al. Clinicopathologic correlations in diabetic retinopathy. Am J Ophthalmol 1977;95:1215-20.
4. Ashton N. Retinal neovascularization in health and disease. Am J Ophthalmol 1957;44:7-24.
5. Sivalingham A, Kenney J, Benson W, et al. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990;108:869-72.
6. Fredj-Reggrobelet D, Baudouin C, Negre F, et al. Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy. Ophthalmic Res 1991;23:154-61.
7. Nakamura Y, Morishita R, Higaki J, et al. Hepatocyte growth factor is a novel member of the endotheliumspecific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens 1996;14:1067-72.
8. Wiedermann P Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration. Surv Ophthalmol 1992;36:373-84.
9. Morishita R, Nakamura S, Nakamura Y, et al. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes. Diabetes 1997;46:138-42.
10. King GL, Goodman AD, Buzney S, et al. Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985;75:1028-36.
11. Armstrong D, Augustin AJ, Spengler R, et al. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 1998;212:410-4.
12. Katsura Y, Okano T, Noritake M, et al. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care 1998;21:1759-63.
13. Nishimura M, Nakano K, Ushiyama M, et al. Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy- J Clin Endocrinol Metab 1998;83:195-8.
14. Burgos R, Simo R, Audi L, et al.Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia 1997;40:1107-9.
15. Ambati J, Chalam KV, Chawla DK, et al. Elevated γ-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1997;115:1161-6.
16. Tanaka Y, Katoh S, Hori S, et al. Vascular endothelial growth factor in diabetic retinopathy. Lancet 1997;349:1520-1.
17. Weidner KM, Arakaki N, Hartman G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991;88:7001-5.
18. Miyazawa K, Tsubouchi H, Naka D, et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor, Biochem Biophys Res Commun 1989;163:967-73.
19. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science 1991;251:802-4.
20. Ishiki Y, Ohnishi H, Muto Y, et al. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1991;16:1227-35.
21. Igawa T, Matsumoto K, Kanda S, et al. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 1993;65:61-9.
22. Nakamura Y, Morishita R, Higaki J, et al. Expression of a local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun 1995;215:483-8.
23. Bussolino F, Di Renzo MF, Ziehe M, et al.Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-41
24. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98:741-56.
25. Aiello LP, Avery RI, Arrigg PG, et al.Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, N Engl J Med 1994;331:1480-7.
26. Clermont AC, Aiello LP, Mon F, et a. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997;124:433-46.
27. Amin RH, Frank RN, Kennedy A, et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:36-47.
28. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and micro angiopathy in an adult primate. Ophthalmology 1996;103:1820-8.
29. Mathews MK, Merges C, McLeod DS, et al. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:2729-41.
30. Nakamura Y, Morishita, Nakamura S, et al. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension 1996;28:409-13.
31. Nishimura M, Ushiyama M, Nanbu A, et al. Serum hepatocyte growth factor as a possible indicator of arteriosclerosis. J Hypenens 1997;15:1137-42.
32. Miyazawa K, Shimomura T, Kitamura K, et al. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 1993;268:10024-8.
33. Nakamura Y, Morishita, Higashi J, et al. Differential regulation of local, production in vascular cells, J Hypertens 1996;14(suppl 1):S70 (abstract).
34. Yanagita K, Nagaike M, Ishibashi H, et al. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 1992;182:802-9.
35. Kono S, Nagaike M, Matsumoto K, et al. Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs. Biochem Biophys Res Commun 1992;186:991-8.
36. Matsumoto K, Nakamura T. Roles of HGF as a pleiotropic factor in organ regeneration. In: Goldberg ID, Rosen EM, eds. Hepatocyte growth factor-scatter factor (HGF-SF) and the C-Met receptor. Basle: Birkhauser Verlag, 1993:225-49.
37. Aiello LP, Northrup JM, Keyt BA, et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995;113:1538-44.
38. Weng J, Liang Q, Mohan RR, et al. Hepatocyte growth factor, keratinocyte growth factor, and other growth factorreceptor systems in the lens. Invest Ophthalmol Vis Sci 1997;38:1543-54.